These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19900229)

  • 21. Short-term isocaloric fructose restriction lowers apoC-III levels and yields less atherogenic lipoprotein profiles in children with obesity and metabolic syndrome.
    Gugliucci A; Lustig RH; Caccavello R; Erkin-Cakmak A; Noworolski SM; Tai VW; Wen MJ; Mulligan K; Schwarz JM
    Atherosclerosis; 2016 Oct; 253():171-177. PubMed ID: 27451002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma apolipoprotein C-III transport in centrally obese men: associations with very low-density lipoprotein apolipoprotein B and high-density lipoprotein apolipoprotein A-I metabolism.
    Chan DC; Nguyen MN; Watts GF; Barrett PH
    J Clin Endocrinol Metab; 2008 Feb; 93(2):557-64. PubMed ID: 18000086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein C-III as a Potential Modulator of the Association Between HDL-Cholesterol and Incident Coronary Heart Disease.
    Jensen MK; Rimm EB; Furtado JD; Sacks FM
    J Am Heart Assoc; 2012 Apr; 1(2):. PubMed ID: 23130121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HDL Containing Apolipoprotein C-III is Associated with Insulin Sensitivity: A Multicenter Cohort Study.
    Yamamoto R; Jensen MK; Aroner S; Furtado JD; Rosner B; Hu FB; Balkau B; Natali A; Ferrannini E; Baldi S; Sacks FM
    J Clin Endocrinol Metab; 2021 Jul; 106(8):e2928-e2940. PubMed ID: 33839794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Very-Low-Density Lipoprotein-Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-III.
    Pechlaner R; Tsimikas S; Yin X; Willeit P; Baig F; Santer P; Oberhollenzer F; Egger G; Witztum JL; Alexander VJ; Willeit J; Kiechl S; Mayr M
    J Am Coll Cardiol; 2017 Feb; 69(7):789-800. PubMed ID: 28209220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ApoE and apoC-III-defined HDL subtypes: a descriptive study of their lecithin cholesterol acyl transferase and cholesteryl ester transfer protein content and activity.
    Amaya-Montoya M; Pinzón-Cortés JA; Silva-Bermúdez LS; Ruiz-Manco D; Pérez-Matos MC; Jiménez-Mora MA; Mendivil CO
    Lipids Health Dis; 2020 May; 19(1):106. PubMed ID: 32450892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma Apolipoproteins Predicting the Occurrence and Severity of Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus.
    Zhang X; Nie Y; Gong Z; Zhu M; Qiu B; Wang Q
    Front Endocrinol (Lausanne); 2022; 13():915575. PubMed ID: 35937834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-sectional study of complement C3 as a coronary risk factor among men and women.
    Onat A; Uzunlar B; Hergenç G; Yazici M; Sari I; Uyarel H; Can G; Sansoy V
    Clin Sci (Lond); 2005 Feb; 108(2):129-35. PubMed ID: 15487975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triglyceride/HDL-cholesterol ratio is an independent predictor for coronary heart disease in a population of Iranian men.
    Hadaegh F; Khalili D; Ghasemi A; Tohidi M; Sheikholeslami F; Azizi F
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):401-8. PubMed ID: 19091534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The risk of cardiovascular events with increased apolipoprotein CIII: A systematic review and meta-analysis.
    Wyler von Ballmoos MC; Haring B; Sacks FM
    J Clin Lipidol; 2015; 9(4):498-510. PubMed ID: 26228667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Independent regulation of plasma apolipoprotein C-II and C-III concentrations in very low density and high density lipoproteins: implications for the regulation of the catabolism of these lipoproteins.
    Le NA; Gibson JC; Ginsberg HN
    J Lipid Res; 1988 May; 29(5):669-77. PubMed ID: 3411241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein C-III Levels and Incident Coronary Artery Disease Risk: The EPIC-Norfolk Prospective Population Study.
    van Capelleveen JC; Bernelot Moens SJ; Yang X; Kastelein JJP; Wareham NJ; Zwinderman AH; Stroes ESG; Witztum JL; Hovingh GK; Khaw KT; Boekholdt SM; Tsimikas S
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1206-1212. PubMed ID: 28473441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Major influence of dysfunctions of protective serum proteins on cardiometabolic risk among Turks and gender difference].
    Onat A; Hergenç G; Can G
    Turk Kardiyol Dern Ars; 2009 Sep; 37(6):425-34. PubMed ID: 20019460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship of lipoprotein-associated apolipoprotein C-III with lipid variables and coronary artery disease risk: The EPIC-Norfolk prospective population study.
    van Capelleveen JC; Lee SR; Verbeek R; Kastelein JJP; Wareham NJ; Stroes ESG; Hovingh GK; Khaw KT; Boekholdt SM; Witztum JL; Tsimikas S
    J Clin Lipidol; 2018; 12(6):1493-1501.e11. PubMed ID: 30249512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?
    Chan DC; Chen MM; Ooi EM; Watts GF
    Int J Clin Pract; 2008 May; 62(5):799-809. PubMed ID: 18201179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma turnover of HDL apoC-I, apoC-III, and apoE in humans: in vivo evidence for a link between HDL apoC-III and apoA-I metabolism.
    Cohn JS; Batal R; Tremblay M; Jacques H; Veilleux L; Rodriguez C; Mamer O; Davignon J
    J Lipid Res; 2003 Oct; 44(10):1976-83. PubMed ID: 12867543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discordance of Low-Density Lipoprotein and High-Density Lipoprotein Cholesterol Particle Versus Cholesterol Concentration for the Prediction of Cardiovascular Disease in Patients With Metabolic Syndrome and Diabetes Mellitus (from the Multi-Ethnic Study of Atherosclerosis [MESA]).
    Tehrani DM; Zhao Y; Blaha MJ; Mora S; Mackey RH; Michos ED; Budoff MJ; Cromwell W; Otvos JD; Rosenblit PD; Wong ND
    Am J Cardiol; 2016 Jun; 117(12):1921-7. PubMed ID: 27156827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associations between smoking, components of metabolic syndrome and lipoprotein particle size.
    Slagter SN; van Vliet-Ostaptchouk JV; Vonk JM; Boezen HM; Dullaart RP; Kobold AC; Feskens EJ; van Beek AP; van der Klauw MM; Wolffenbuttel BH
    BMC Med; 2013 Sep; 11():195. PubMed ID: 24228807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions of the apolipoprotein C-III 3238C>G polymorphism and alcohol consumption on serum triglyceride levels.
    Ruixing Y; Yiyang L; Meng L; Kela L; Xingjiang L; Lin Z; Wanying L; Jinzhen W; Dezhai Y; Weixiong L
    Lipids Health Dis; 2010 Aug; 9():86. PubMed ID: 20716347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.